Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Deal Details

C/PIndustryStatusTicker(s)Issuer(s)Size(m)TranchesRegionDate
IGC
HLTH
PRCD
USZ
University Hospital of ZurichCHF300
2EMEA
Aug 29, 2024
currency
CHF
size (m)
150.000
maturity
Sep 27, 2032
type
Fixed
tenor
8.000
call
-
registration
-
benchmark
Swaps
ranking
Sr. Unsecured
moody's
-
s&p
-
fitch
-
size description
-
re-open/tap
No
ipt
MS+80-90
ipt-pxd
-
guidance
MS+78-80
spread
78
coupon
1.50%
spread set
-
price
100.30000
yield
1.46%
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
billing & delivering
active leads
-
joint leads
-
passive leads
-
co-managers
-
coordinating managers
-
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
billing & delivering
active leads
-
joint leads
-
passive leads
-
co-managers
-
coordinating managers
-
currency
CHF
size (m)
150.000
maturity
Sep 26, 2036
type
Fixed
tenor
12.000
call
-
registration
-
benchmark
Swaps
ranking
Sr. Unsecured
moody's
-
s&p
-
fitch
-
size description
-
re-open/tap
No
ipt
MS+88-98
ipt-pxd
-
guidance
MS+86-88
spread
86
coupon
1.65%
spread set
-
price
100.32300
yield
1.62%
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
billing & delivering
active leads
-
joint leads
-
passive leads
-
co-managers
-
coordinating managers
-
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
billing & delivering
active leads
-
joint leads
-
passive leads
-
co-managers
-
coordinating managers
-
Tranche Comments
8 yr: Comments: CHF150m (Upsized from CHF100m) 2-tr snr unsec public. Aa+(ZKB)/AA(fedafin). ZKB(sole). IPTs 8yr MS+80/+90. Guidance MS+78/+80 for min 100m. Set MS+78 for 150m. Final Govt+126.4. PP: Yes. XD: Yes; 12 yr: Comments: CHF150m (Upsized from CHF100m) 2-tr snr unsec public. Aa+(ZKB)/AA(fedafin). ZKB(sole). IPTs 12yr MS+88/+98. Guidance MS+86/+88, for min 100m. SetMS+86 for 150m. Final Govt+126.4. PP: Yes. XD: Yes;
Deal Comments
Public Bond

Commentary

Explore all other Commentary & Deal Flow

Deal Flow

Explore all other Commentary & Deal Flow
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.